Clinical Trial Update: Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Trizivir, Kaletra, and Combivir for prevention of mother-to-child transmission of HIV; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• COMBIVIR (Lamivudine and Zidovudine)
• Kaletra (lopinavir)
• Trizivir

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2017-06-05